Mason Street Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Mason Street Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $960,822 - $1.28 Million	-16,200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $8,277 - $10,866	164 Added 1.02%	16,200 $969,000
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $11,589 - $14,049	223 Added 1.41%	16,036 $964,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $39,362 - $67,056	1,278 Added 8.79%	15,813 $830,000
Q4 2019 Feb 19, 2020	BUY	$36.31 - $46.83 $14,923 - $19,247	411 Added 2.91%	14,535 $658,000
Q3 2019 Nov 05, 2019	BUY	$35.66 - $44.99 $503,661 - $635,438	14,124 New	14,124 $538,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.